Bionano Genomics (BNGO) said Thursday it is offering 9.88 million common shares and series C and series D warrants, each to purchase additional 9.88 million shares, in a registered direct offering for $3 million.
Shares and warrants will be sold separately, with both series having an exercise price of $0.3039 per share, the company said in a regulatory filing.
The series C warrants expire five years after stockholder approval, while the series D warrants expire 18 months after approval, Bionano said.
Bionano plans to use the net proceeds, together with its existing cash and cash equivalents and available-for-sale securities, for general corporate purposes.
Bionano shares fell more than 11% in recent trading.
Price: 0.30, Change: -0.04, Percent Change: -11.30
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。